Primaire tabs
Exporteer 189 resultaten:
Filters: Auteur is Johan Van der Heyden
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium : Results of the second data collection (28/09/21-23/02/22),
, 21/04/2022, Brussels, Belgium, p.13, (2022)
QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian Health Interview Survey,
, BMC Public Health, Jan-12-2022, Volume 22, Issue 1, (2022)
Unit Response and Costs in Web Versus Face-To-Face Data Collection: Comparison of Two Cross-sectional Health Surveys.,
, J Med Internet Res, 2022 01 07, Volume 24, Issue 1, (2022)
Validity of self-reported air pollution annoyance to assess long-term exposure to air pollutants in Belgium,
, Environmental Research, Jan-07-2022, Volume 210, (2022)
Assessing polypharmacy in the older population: Comparison of a self‐reported and prescription based method,
, Pharmacoepidemiology and Drug Safety, Jan-12-2021, Volume 30, Issue 12, (2021)
Association between polypharmacy and mortality in the community-dwelling older population: a data linkage study,
, International Journal of Epidemiology, Feb-09-2021, Volume 50, Issue Supplement_1, (2021)
Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020,
, Eurosurveillance, Feb-12-2021, Volume 26, Issue 48, (2021)
Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium,
, 08/2021, Belgium, p.48, (2021)
Hepatitis C virus prevalence in Belgium,
, Experimental Results, 2021, Volume 2, (2021)
Hepatitis C virus prevalence in Belgium,
, Experimental Results, 2021, Volume 2, (2021)
The Impact of the covid-19 on satisfaction with social contacts,
, European Public Health conference, 20/10/21, Volume 14th edition, (2021)
Oversterfte tijdens de eerste en tweede golf van COVID-19-epidemie in België,
, 08/2021, Belgium, p.51, (2021)
Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies.,
, BMC Infect Dis, 2021 Sep 14, Volume 21, Issue 1, (2021)
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study,
, 25/11/2021, Brussels, Belgium, p.80, (2021)
Septième enquête de santé COVID-19 : résultats préliminaires,
, 16/09/2021, (2021)
Sixième enquête de santé COVID-19 : résultats préliminaires,
, 13/04/2021, (2021)
Surmortalité durant la 1re et 2e vague de l'épidémie de COVID-19 en Belgique,
, 08/2021, p.48, (2021)
Surveillance de la mortalité COVID-19 en Belgique, épidémiologie et méthodologie durant la 1re et 2e vague (mars 2020 - 14 février 2021),
, 09/2021, Belgium, p.42, (2021)
Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020 - 14 February 2021),
, 09/2021, Belgium, p.42, (2021)
Surveillance van COVID-19 gerelateerde mortaliteit in België, epidemiologie en methodologie tijdens 1e en 2e golf (maart 2020 - 14 februari 2021),
, 09/2021, Belgium, p.42, (2021)
Validity of self-reported data to assess the prevalence of overweight, hypertension and cholesterol,
, European Journal of Public Health, Aug-10-2022, Volume 31, Issue Supplement_3, (2021)
Zesde COVID-19-Gezondheidsenquête. Eerste resultaten,
, 13/04/2021, (2021)
Zevende COVID-19-Gezondheidsenquête. Eerste resultaten,
, 16/09/2021, (2021)
All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century.,
, Arch Public Health, 2020 Nov 13, Volume 78, Issue 1, (2020)